vcfirmsdirectory.com

Venture capital · Early stage · Est. 2009

Mission BioCapital

Mission BioCapital is a life science venture firm with offices in San Francisco and Cambridge. It backs early-stage therapeutics companies, and also medtech and diagnostics, and runs shared lab spaces and a Platinum Program for startups.

San Francisco · Cambridge · CopenhagenRegistered · Cambridge
New investments · 12 months
Fund vehiclesPublic
4
4 active · US private fund
First chequePublic
Up to $500K
From the firm’s website
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: missionbiocapital.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Mission BioCapital joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Mission BioCapital right for your round?

Is Mission BioCapital a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
4
4 active · US private fund
SEC adviser filings
First chequePublic
Up to $500K
From the firm’s website
missionbiocapital.com
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

MISSION BIOCAPITAL V LPUS private fund · Active · United States · $243.7M gross assets · filed 26 Mar 2026
BIOINNOVATION CAPITAL I LPUS private fund · Active · United States · $210.9M gross assets · filed 26 Mar 2026
MISSION BIOCAPITAL VI LPUS private fund · Active · United States · $153.8M gross assets · filed 26 Mar 2026
MISSION BIOCAPITAL PLATINUM PROGRAM HOLDINGS, LLCUS private fund · Active · United States · $11.8M gross assets · filed 26 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds Mission BioCapital joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

3 rounds in the last 12 months

Round sizes, Mission BioCapital’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

March BiosciencesAsherbioApplaud MedicalCavalry BiosciencesSensorium TherapeuticsQurAlisNocion TherapeuticsARase TherapeuticsAvexegenArkuda Therapeuticsand 86 more

Portfolio and exits

Every company Mission BioCapital backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Mission BioCapital puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Mission BioCapital

Events where Mission BioCapital’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Mission BioCapital’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

26 Mar 2026Fund filingForm ADV filed by MISSION BIOCAPITAL: 1 private fund, $210.9M in gross assets.SEC Form ADV · public record
26 Mar 2026Fund filingForm ADV filed by MISSION BIOCAPITAL: 3 private funds, $409.3M in gross assets.SEC Form ADV · public record
8 Jan 2026New deal
8 Jan 2026New deal
7 Jan 2026New deal
12 Dec 2024New deal
3 Mar 2024New deal

Founders also look at

Frequently asked questions

Mission BioCapital is based in Cambridge, United States. It also has offices in San Francisco and Copenhagen.

In 2009.

4 fund vehicles are on public registers (SEC adviser filings), including MISSION BIOCAPITAL V LP, BIOINNOVATION CAPITAL I LP and MISSION BIOCAPITAL VI LP.

Stages: Early stage. Sectors: Biotech, Life sciences, Medtech. From the firm’s own website.

The firm provides early capital and a collaborative platform, including shared labs, to life science entrepreneurs, supporting them from the first experiment toward the clinic. It prefers novel therapeutics, is disease- and modality-agnostic, and adds mentorship, operating help and company-building support. From the firm’s own website.

Up to $500K per investment, according to the firm’s own website.

Mission BioCapital lists 96 portfolio companies on its website, including March Biosciences, Asherbio, Applaud Medical, Cavalry Biosciences and Sensorium Therapeutics.

Firms whose websites list some of the same companies include AWESOME ENABLERS, L.L.C., Inkef and RA Capital.

Know before Mission BioCapital’s next round is announced.

PRO tracks Mission BioCapital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Mission BioCapitalGet Mission BioCapital’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.